Francisco Leon - 27 Dec 2022 Form 4 Insider Report for Provention Bio, Inc.

Role: Chief Scientific Officer
Signature: /s/ Thierry Chauche, as attorney-in-fact
Issuer symbol: N/A
Transactions as of: 27 Dec 2022
Net transactions value: -$80,055
Form type: 4
Filing time: 29 Dec 2022, 15:01:33 UTC
Previous filing: 27 Dec 2022
Next filing: 30 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRVB	Common Stock	Options Exercise	$26,685	+10,674	+0.68%	$2.50^*	1,583,674	27 Dec 2022	Direct
transaction	PRVB	Common Stock	Sale	$106,740	-10,674	-0.67%	$10.00	1,573,000	27 Dec 2022	Direct
holding	PRVB	Common Stock						1,000,000	27 Dec 2022	By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PRVB	Stock Option (right to buy)	Options Exercise	$0	-10,674	-2%	$0.000000	529,103	27 Dec 2022	Common Stock	10,674	$2.50	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option is fully vested.